Effect of cefazolin and vancomycin on osteoblasts in vitro
- PMID: 8981903
Effect of cefazolin and vancomycin on osteoblasts in vitro
Abstract
The effect of cefazolin and vancomycin on osteoblast-like cells was studied. Cells from the MG-63 human osteosarcoma cell line were grown in antibiotic free media and exposed to concentrations of cefazolin and vancomycin at order of magnitude intervals between 0 and 10,000 microg/ml. For cefazolin, a second interval was performed between 100 and 1000 microg/ml to define toxic levels more accurately. Cell number and 3H-thymidine incorporation at 0, 24, and 72 hours were determined. The results of this study show that local levels of vancomycin of 1000 microg/ml and less have little or no effect on osteoblast replication, and concentrations of 10,000 microg/ml cause cell death. Concentrations of cefazolin of 100 microg/ml and less have little or no effect on osteoblast replication, 200 microg/ml significantly decrease cell replication, and 10,000 microg/ml cause cell death. The authors conclude that vancomycin is less toxic than is cefazolin to osteoblasts at higher concentrations and may be a better antibiotic for local administration in the treatment of similarly sensitive bacterial infections.
Similar articles
-
Effect of ciprofloxacin on the proliferation of osteoblast-like MG-63 human osteosarcoma cells in vitro.J Orthop Res. 1998 Jul;16(4):509-12. doi: 10.1002/jor.1100160417. J Orthop Res. 1998. PMID: 9747794
-
Toxic effect of rifampicin on human osteoblast-like cells.J Orthop Res. 2001 Sep;19(5):950-4. doi: 10.1016/S0736-0266(01)00022-5. J Orthop Res. 2001. PMID: 11562146
-
Bone toxicity of locally applied aminoglycosides.J Orthop Trauma. 1995;9(5):401-6. doi: 10.1097/00005131-199505000-00007. J Orthop Trauma. 1995. PMID: 8537843
-
Cellular and molecular effects of growth hormone and estrogen on human bone cells.APMIS Suppl. 1997;71:1-30. APMIS Suppl. 1997. PMID: 9357492 Review.
-
The role of vancomycin in the treatment paradigm.Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S51-7. doi: 10.1086/491714. Clin Infect Dis. 2006. PMID: 16323121 Review.
Cited by
-
Local Intramedullary Delivery of Vancomycin Can Prevent the Development of Long Bone Staphylococcus aureus Infection.PLoS One. 2016 Jul 29;11(7):e0160187. doi: 10.1371/journal.pone.0160187. eCollection 2016. PLoS One. 2016. PMID: 27472197 Free PMC article.
-
Research into biocompatibility and cytotoxicity of daptomycin, gentamicin, vancomycin and teicoplanin antibiotics at common doses added to bone cement.Jt Dis Relat Surg. 2020;31(2):328-334. doi: 10.5606/ehc.2020.74943. Epub 2020 Jun 18. Jt Dis Relat Surg. 2020. PMID: 32584733 Free PMC article.
-
Study of antibiotic efficacy of topical vancomycin powder in treatment of infected mandibular fractures and soft tissue surgical site infections.J Family Med Prim Care. 2019 Oct 31;8(10):3340-3344. doi: 10.4103/jfmpc.jfmpc_661_19. eCollection 2019 Oct. J Family Med Prim Care. 2019. PMID: 31742165 Free PMC article.
-
Management of Infected Bone Defects of the Lower Extremities by Three-Stage Induced Membrane Technique.Med Sci Monit. 2020 Feb 12;26:e919925. doi: 10.12659/MSM.919925. Med Sci Monit. 2020. Retraction in: Med Sci Monit. 2021 Aug 06;27:e934259. doi: 10.12659/MSM.934259. PMID: 32047141 Free PMC article. Retracted.
-
Repeated serum alkaline phosphatase measurements in the treatment of childhood acute bone and joint infections with high doses of antibiotics.Ann Lab Med. 2013 Sep;33(5):375-8. doi: 10.3343/alm.2013.33.5.375. Epub 2013 Aug 8. Ann Lab Med. 2013. PMID: 24003432 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical